Expertise in
1
conditions

Hidemitsu Kurosawa

Mibu, JP 
Expertise in
1
conditions
Mibu, JP 

Overview

Hidemitsu Kurosawa practices practicing medicine in Mibu, Japan.

Kurosawa is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Leukocyte Adhesion Deficiency Type 1, WT1-Related Wilms Tumor Syndromes, Leukemia, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 30 peer reviewed articles.

Locations

Mibu, Japan
Other Locations
Tokyo, Japan
Shintoshin, 3308777, Japan
Tochigi, Japan
Shimotsuga, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

30 Total Publications

Different changes in the biomarker C-terminal telopeptides of type II collagen (CTX-II) following intra-articular injection of high molecular weight hyaluronic acid and oral non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis: a multi-center randomized controlled study.
Different changes in the biomarker C-terminal telopeptides of type II collagen (CTX-II) following intra-articular injection of high molecular weight hyaluronic acid and oral non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis: a multi-center randomized controlled study.
Journal: Osteoarthritis and cartilage
Published: July 28, 2021

Frequently Asked Questions about Hidemitsu Kurosawa

Is Hidemitsu Kurosawa a top-rated expert for Acute Monoblastic Leukemia (AmoL)?

MediFind is an objective health platform that identifies experts based on real-world data. Hidemitsu Kurosawa is classified as an Advanced expert for Acute Monoblastic Leukemia (AmoL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hidemitsu Kurosawa participate in research or clinical trials?

Yes. Hidemitsu Kurosawa has published 30 articles and abstracts on conditions like Acute Monoblastic Leukemia (AmoL). You can view a list of Hidemitsu Kurosawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kurosawa's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile